PHARMACOECONOMIC STUDY OF DRUG UTILIZATION AND COST OF TREATMENT IN PATIENTS HOSPITALIZED WITH CHEST DISEASES ( UPPER AND LOWER RESPIRATORY TRACT INFE

Abstract

In the Study design, the study was a randomized before-and-after study in the same group of patients for each of the two drug devices under study. • The Selection of comparators was chosen on the bases of administrating the same active constituent in different devices (the aerolizer inhaler and the turbuhaler). • The primary health outcome was the rate improvement of the pulmonary function test results of asthmatic patients. The responses were compared and both groups of patients were equally improved in the same period of time and by the same dose of drug without noticing acute side effects.